Loading…
for educational and safety purposes
sci-wiki~$open stack neuro-vascularity
delivery and utilisation, with the evidence gradient running the opposite way from usual
Ginkgo Bilobathe most-studied botanical for this, with a genuinely mixed literaturewith food4 items; 2 structures drawn from pubchem, 2 drawn generically because pubchem has no record of the name.
⚠️ COMPANION TO THE BLOOD-FLOW BOOST STACK, AND THE DISTINCTION IS WORTH STATING: that one is systemic oxygen delivery through PDE5 inhibition, ITPP and roxadustat. This one is cerebral perfusion and neurovascular coupling specifically.
⚠️ THE EVIDENCE GRADIENT RUNS THE OPPOSITE WAY FROM MOST STACKS HERE. The two natural items have the larger human literature and the prescription drug has the narrowest licensed use, which is the reverse of the usual pattern and is worth noticing.
Ginkgo biloba is the most-studied botanical for cerebral blood flow, and its literature is large and genuinely mixed. ⚠️ The big trials in dementia prevention were null, and saying so is more useful than citing only the positive ones. ⚠️ Its interaction surface is real: it has antiplatelet activity, which matters alongside anticoagulants, and it is both a substrate and an inhibitor of cytochrome P450 enzymes.
Cocoa flavanols act through epicatechin driving nitric-oxide-dependent vasodilation, and they are among the better-evidenced items anywhere in this roster for flow-mediated dilation specifically, with real randomised human data.
⚠️ NIMODIPINE IS THE SERIOUS ONE AND IT IS A PRESCRIPTION DRUG. It is an L-type calcium channel blocker lipophilic enough to reach the brain, licensed specifically for vasospasm after subarachnoid haemorrhage. It is not a nootropic and it is not a supplement: it lowers blood pressure, and its cognitive use is off-label and thinly evidenced compared with its licensed one.
Intranasal insulin is the best-evidenced item here for cognition itself, with multiple human trials in memory and in Alzheimer's and mild cognitive impairment populations.
Vasodilation by two independent routes, plus a flow-and-platelet botanical, plus a metabolic item that improves how the tissue uses what arrives. That is a genuine pairing rather than four vasodilators.
Cocoa flavanols work through nitric oxide: epicatechin raises endothelial nitric oxide availability, producing flow-mediated dilation, which is measurable and has been measured repeatedly in humans. Nimodipine works through calcium channel blockade, relaxing vascular smooth muscle by a completely separate mechanism, and it is lipophilic enough to reach cerebral vessels specifically.
Ginkgo contributes flow effects and antiplatelet activity, which is a rheological contribution rather than a calibre one.
Intranasal insulin is the item that is not about delivery at all. It acts on brain insulin signalling and therefore on neuronal glucose utilisation, which is the demand side. Delivering more blood to tissue that cannot use it efficiently is half an intervention, and that is the argument for including it.
Cocoa flavanols produce measurable vascular changes within hours and no reliable subjective effect; the endpoint in those trials is an ultrasound measurement, not a feeling.
Ginkgo is slow and its subjective reports are inconsistent, which matches its literature.
Nimodipine is felt mainly through blood pressure, and in a person with normal blood pressure that is a side effect rather than an effect.
This is a stack whose honest readout is not perceptual, and the temptation to escalate looking for a sensation is the predictable failure.
⚠️ NIMODIPINE LOWERS BLOOD PRESSURE, which is the named mechanism and the reason it is a prescription drug; combining it with other antihypertensives, or taking it with normal blood pressure, risks hypotension. It also has significant grapefruit and CYP3A4 interactions. ⚠️ GINKGO HAS ANTIPLATELET ACTIVITY, which matters alongside anticoagulants, antiplatelets or before surgery. ⚠️ Intranasal insulin can cause hypoglycaemia and is a different proposition entirely for anyone diabetic or on glucose-lowering therapy.
nothing flaggedcurated roster
every pair here reads as compatible on the mechanisms the site holds. that is the absence of a known conflict, not a clearance.
1 of 4 in one basketRUPharma
Cocoa Flavanols, Intranasal Insulin have no outlet here at all.
2 of 4 priced
2 of these carry no listed price, so there is no honest total to print; the lines above are what can actually be costed.
1 overlapsame lever, twice
interested in protocols? join the discord; that is where dosing, timing and the practical side get discussed.
the sci-wiki publishes this as a description of what these compounds do together, not as a recommendation to take them. Nothing here is medical advice.